• E-ISSN 2583-0104
  • Follow us

International Journal of Preclinical and Clinical Research

Article

International Journal of Preclinical and Clinical Research

Year: 2022, Volume: 3, Issue: 3, Pages: 74-77

Case Report

Mixed Connective Tissue Disorder: A Rare Case Report

Received Date:19 October 2022, Accepted Date:23 November 2022, Published Date:13 December 2022

Abstract

MCTD is a rare disease with overlapping features of many connective tissue disorder and the presence of positive anti-U1RNP antibodies with anti-ssA (Ro), anti-ssB (La) being negative. We report a case with fever and edema of upper limb and lower limb small joints associated with violaceous discolouration which on further evaluation led to diagnosis of MCTD. A female aged 44 years presented with history of fever of moderate degree with no diurnal variation and subsides on taking medication for 7 days and had also noticed ecchymoses followed by maculopapular rashes (violaceous) associated with tenderness of fingers and toes (more on exposure to cold). On further evaluation led to a diagnosis of MCTD. This case report urges the clinicians to exercise great caution for connective tissue diseases in patient presenting with similar history. This rare case of disease is uncommon in the available literature, especially for this ethnicity or region. This report should be of great interests to all diagnosticians of internal medicine.

 

Keywords: Mixed connective tissue disorder, Raynaud’s phenomenon, sclerodactyly, Anti-U1nRNP antibody, Scleroderma

References

  1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) The American Journal of Medicine. 1972;52(2):148–159. Available from: https://doi.org/10.1016/0002-9343(72)90064-2
  2. Kahn MF, Bourgeois P, Aeschlimann A, Truchis PD. Mixed connective tissue disease after exposure to polyvinyl chloride. J Rheumatol. 1989;16(4):533–538. Available from: https://pubmed.ncbi.nlm.nih.gov/2746593/
  3. Gunnarsson R, Molberg Ø, Gilboe IMM, Gran JT. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Annals of the Rheumatic Diseases. 2011;70(6):1047–1051. Available from: https://doi.org/10.1136/ard.2010.143792
  4. Hench PK, Edington TS, Tam EM. The Evolving clinical spectrum of mixed connective tissue disease. Arthritis Rheum. 1975;18:404–412.
  5. Haroon N, Nisha RS, Chandran V, Bharadwaj A. Pulmonary hypertension not a major feature of early mixed connective tissue disease: A prospective clinicoserological study. J Postgrad Med. 2005;51(2):104–111. Available from: https://pubmed.ncbi.nlm.nih.gov/16006700/
  6. Ortega-Hernandez ODD, Shoenfeld Y. Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment. Best Practice & Research Clinical Rheumatology. 2012;26(1):61–72. Available from: https://doi.org/10.1016/j.berh.2012.01.009
  7. Mok CC, Ho LY, To CH. Rituximab for refractory polymyositis: An open-label prospective study. J Rheumatol. 2007;34(9):1864–1872. Available from: https://pubmed.ncbi.nlm.nih.gov/17722224/

Copyright

© 2022 Sunil et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Published By Basaveshwara Medical College & Hospital, Chitradurga, Karnataka

DON'T MISS OUT!

Subscribe now for latest articles and news.